SPAC6B12.04c Antibody

What is SPAC6B12.04c and what is its function in fission yeast?

SPAC6B12.04c is a gene in Schizosaccharomyces pombe (fission yeast) that encodes an uncharacterized aminotransferase belonging to class I and II (EC 2.6.1.-) . Biochemically, it's predicted to function in amino acid metabolism by catalyzing the transfer of amino groups between amino acids and α-keto acids. Research suggests potential involvement in cell wall integrity pathways, similar to other proteins characterized in S. pombe cellular processes . The gene appears in multiple genomic analyses of fission yeast, including studies examining gene expression profiles under various conditions . Though not fully characterized functionally, it represents an important target for researchers studying metabolic pathways in model organisms.

What experimental applications is the SPAC6B12.04c antibody suitable for?

Based on available data, the SPAC6B12.04c antibody is suitable for multiple experimental applications:

• ELISA (EIA): For quantitative detection of the protein

• Western Blot (WB): For identification and quantification of the protein in cell extracts

The antibody is typically generated in rabbit hosts with specificity against Schizosaccharomyces pombe (strain 972/ATCC 24843) proteins . Most commercially available preparations are purified through antigen affinity methods to ensure high specificity and reduced background . As with other S. pombe antibodies, it may potentially be used for immunofluorescence microscopy and immunoprecipitation studies, though these applications would require validation for this specific antibody.

What are the recommended protocols for using SPAC6B12.04c antibody in Western blot analysis?

For optimal Western blot results with SPAC6B12.04c antibody, the following protocol is recommended:

Sample Preparation:

• Harvest S. pombe cells at mid-log phase (OD600 ~0.5-1.0)

• Lyse cells using methods similar to those described for other S. pombe proteins

• Extract total protein using TRIzol or dedicated protein extraction buffers

• Quantify protein concentration using Bradford or BCA assay

Western Blot Procedure:

• Separate 10-30 μg protein on 10-12% SDS-PAGE gels

• Transfer to nitrocellulose or PVDF membranes

• Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with primary SPAC6B12.04c antibody (typical dilution 1:1000-1:2000) overnight at 4°C

• Wash 3-5 times with TBST

• Incubate with HRP-conjugated secondary anti-rabbit antibody (1:5000-1:10000) for 1 hour

• Develop using ECL detection system

Controls:

• Include wild-type S. pombe lysate as positive control

• Use appropriate loading controls such as GAPDH or actin

• Consider including lysate from a SPAC6B12.04c deletion strain as negative control if available

How should researchers store and handle SPAC6B12.04c antibody samples?

Proper storage and handling are critical for maintaining antibody functionality:

Storage Conditions:

• Store at -20°C or -80°C for long-term storage

• Avoid repeated freeze-thaw cycles (aliquot upon receipt)

• For working solutions, store at 4°C for up to two weeks

• If needed, add preservatives (e.g., sodium azide at 0.02%) for longer storage at 4°C

Handling Guidelines:

• Centrifuge briefly before opening to collect solution at the bottom

• Use sterile techniques when handling antibody solutions

• Avoid contamination with microorganisms

• Keep on ice during experiments

• Follow manufacturer's specific recommendations for reconstitution if lyophilized

Stability Information:
Most SPAC6B12.04c antibodies remain stable until the expiration date when stored properly at recommended temperatures .

What positive and negative controls should be used when validating SPAC6B12.04c antibody specificity?

Proper experimental controls are essential for validating antibody specificity:

Positive Controls:

• Wild-type S. pombe cell lysate

• Recombinant SPAC6B12.04c protein (if available)

• TAP-tagged or epitope-tagged SPAC6B12.04c strains

Negative Controls:

• SPAC6B12.04c deletion mutant (ΔSPAC6B12.04c)

• Pre-immune serum from the same animal source

• Secondary antibody-only controls to detect non-specific binding

• Peptide competition assay using the immunizing peptide

Validation Methods:

• Compare band patterns between wild-type and deletion strains

• Verify expected molecular weight (~predicted size for SPAC6B12.04c)

• Confirm signal reduction/elimination in peptide competition assays

• Cross-validate with differently tagged versions of the protein

How can researchers design effective co-immunoprecipitation experiments using SPAC6B12.04c antibody?

For effective co-immunoprecipitation (Co-IP) of SPAC6B12.04c and its interaction partners:

Lysate Preparation:

• Harvest 100 A600 units of cells in logarithmic growth phase

• Wash twice with cold phosphate-buffered saline

• Treat with Zymolyase (Sigma) for 30 minutes to generate spheroplasts

• Lyse cells in a buffer that preserves protein-protein interactions (e.g., TPER lysis buffer )

• Clear lysate by centrifugation (14,000 rpm, 15 minutes, 4°C)

Immunoprecipitation Procedure:

• Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

• Incubate with SPAC6B12.04c antibody (2-5 μg) overnight at 4°C

• Add Protein A/G beads and incubate for additional 2-4 hours

• Wash extensively (4-6 times) with reduced-detergent buffer

• Elute bound proteins with SDS sample buffer or gentle elution buffer

Detection Methods:

• Western blot with SPAC6B12.04c antibody to confirm primary target precipitation

• Western blot with antibodies against suspected interaction partners

• Mass spectrometry analysis for unbiased identification of co-precipitated proteins

Optimization Strategies:

• Test different lysis buffers with varying salt and detergent concentrations

• Try different antibody amounts and incubation times

• Consider crosslinking approaches for capturing transient interactions

• Use tagged versions (e.g., TAP-tagged) as complementary approach

What methods should be used to analyze potential changes in SPAC6B12.04c expression under different experimental conditions?

To effectively analyze SPAC6B12.04c expression changes:

Real-Time Quantitative PCR (RT-qPCR):

• Extract total RNA using TRIzol Reagent

• Treat RNA with DNase I to remove genomic DNA contamination

• Perform reverse transcription using a high-quality kit (e.g., TaKaRa PrimeScript)

• Design specific primers for SPAC6B12.04c (18-25 bp, Tm ~60°C)

• Use reference genes such as act1 or hcs1 for normalization

• Perform qPCR with SYBR Green in technical quadruplicates

• Analyze using comparative Ct method (2^-ΔΔCt)

Sample Experimental Design:

• Test expression under normal growth conditions

• Examine expression during cell cycle progression

• Investigate response to stress conditions (nutritional, oxidative, temperature)

• Compare expression in different genetic backgrounds

Data Analysis Table Example:

How can genome-wide approaches be integrated with SPAC6B12.04c antibody studies to understand protein function?

Integration of genomic approaches with antibody studies provides comprehensive insights:

ChIP-seq Analysis:

• Crosslink S. pombe cells with formaldehyde (1-3%, 5-15 minutes)

• Lyse cells and fragment chromatin to 200-500 bp by sonication

• Immunoprecipitate with SPAC6B12.04c antibody using methods similar to those in published studies

• Prepare libraries from immunoprecipitated DNA

• Sequence using next-generation sequencing platforms

• Analyze data to identify genomic binding sites

RNA-seq Integration:

• Perform RNA-seq on wild-type and SPAC6B12.04c mutant strains

• Identify differentially expressed genes

• Correlate with ChIP-seq binding sites to identify direct targets

• Validate selected targets by RT-qPCR and functional assays

Proteomics Approaches:

• Perform immunoprecipitation followed by mass spectrometry to identify protein complexes

• Use SILAC or TMT labeling for quantitative comparison across conditions

• Integrate with existing interactome data for S. pombe proteins

Data Integration Strategy:

• Map protein-DNA interactions, protein-protein interactions, and expression data

• Apply network analysis to identify functional modules

• Validate key interactions with targeted experiments

• Use computational approaches to predict protein function based on multi-omics data

What strategies should be employed to characterize potential enzymatic activities of SPAC6B12.04c protein?

Since SPAC6B12.04c is predicted to be an aminotransferase, characterizing its enzymatic activity requires:

Protein Purification:

• Express recombinant SPAC6B12.04c in a suitable system (E. coli, yeast)

• Add affinity tag (His6, GST) to facilitate purification

• Purify using affinity chromatography and size exclusion methods

• Verify purity by SDS-PAGE and Western blot with SPAC6B12.04c antibody

• Assess protein folding using circular dichroism spectroscopy

Enzymatic Activity Assays:

• Test general aminotransferase activity using standard coupled assays

• Screen different amino acid and α-keto acid substrates

• Measure activity using spectrophotometric methods

• Determine kinetic parameters (Km, Vmax, kcat)

• Assess cofactor requirements (typically pyridoxal phosphate for aminotransferases)

Inhibition Studies:

• Test classic aminotransferase inhibitors

• Determine IC50 values for effective inhibitors

• Characterize inhibition mechanisms (competitive, non-competitive)

Substrate Specificity Analysis:

• Test activity with different amino acids as amino group donors

• Examine different α-keto acids as amino group acceptors

• Use HPLC or LC-MS to identify reaction products

• Compare activity profile with known aminotransferases

How can CRISPR-Cas9 genome editing be used to study SPAC6B12.04c function in S. pombe?

CRISPR-Cas9 technology offers powerful approaches for functional studies:

Gene Deletion Strategy:

• Design sgRNAs targeting SPAC6B12.04c coding sequence

• Clone sgRNAs into a suitable CRISPR-Cas9 expression vector for S. pombe

• Prepare repair template with selectable marker (e.g., antibiotic resistance)

• Transform S. pombe cells with CRISPR-Cas9 construct and repair template

• Select transformants and verify deletion by PCR and sequencing

• Phenotypically characterize deletion mutants (growth, morphology, stress resistance)

Tagging Approach:

• Design sgRNAs targeting the C-terminus of SPAC6B12.04c

• Create repair template with fluorescent protein (GFP) or epitope tag (FLAG, HA)

• Ensure in-frame fusion and include flexible linker sequence

• Transform, select, and verify correct integration

• Use tagged protein for localization studies, ChIP, and protein interaction analyses

Point Mutation Generation:

• Identify conserved catalytic residues based on aminotransferase domains

• Design sgRNAs targeting these regions

• Create repair templates with desired mutations

• Introduce mutations using CRISPR-Cas9

• Compare mutant phenotypes with complete deletion

Advantages Over Traditional Methods:

• Higher efficiency compared to conventional homologous recombination

• Reduced off-target effects with optimized sgRNAs

• Ability to generate multiple mutations simultaneously

• Creation of conditional alleles through inducible systems

How can researchers investigate the role of SPAC6B12.04c in cell wall integrity and septum formation?

To study potential roles in cell wall integrity:

Phenotypic Analysis:

• Compare wild-type and SPAC6B12.04c mutant strains under various conditions:

  • Temperature stress (25°C, 30°C, 36°C)

  • Cell wall-disrupting agents (calcofluor white, congo red)

  • Osmotic stress (sorbitol, KCl)

  • Zymolyase sensitivity assays

• Examine cell morphology and septation using DIC and fluorescence microscopy

Cell Wall Component Analysis:

• Fractionate cell wall components following protocols similar to those in Sethi et al.

• Quantify β-1,3-glucan, α-glucan, and mannan content

• Compare profiles between wild-type and mutant strains

• Examine changes under different growth conditions

Ultrastructural Studies:

• Prepare cells for transmission electron microscopy

• Analyze septum structure, particularly the primary septum

• Examine cell wall thickness and organization

• Quantify ultrastructural defects in mutants

Genetic Interaction Studies:

• Create double mutants with known cell wall synthesis genes

• Test for synthetic lethality or rescue effects

• Examine epistatic relationships with genes in related pathways

• Correlate findings with biochemical and phenotypic data

Example Data Table - Cell Wall Analysis:

What are the most common technical issues when working with SPAC6B12.04c antibody and how can they be resolved?

Common technical challenges and their solutions include:

High Background in Western Blots:

• Problem: Non-specific binding creating multiple bands or smears

• Solutions:

  • Increase blocking time or concentration (try 5% BSA instead of milk)

  • Use more stringent washing (increase time, detergent concentration, or number of washes)

  • Optimize antibody dilution (try 1:2000-1:5000 range)

  • Pre-absorb antibody with non-specific proteins

  • Include 0.1-0.5% Tween-20 in antibody dilution buffer

Weak or No Signal:

• Problem: Low detection of target protein

• Solutions:

  • Increase protein loading (30-50 μg per lane)

  • Decrease antibody dilution (1:500-1:1000)

  • Extend primary antibody incubation (overnight at 4°C)

  • Use more sensitive detection systems (enhanced ECL)

  • Optimize extraction methods to ensure target protein solubilization

  • Check protein transfer efficiency with reversible staining

Cross-Reactivity:

• Problem: Antibody binding to unintended proteins

• Solutions:

  • Validate with knockout/deletion controls

  • Use more stringent washing conditions

  • Consider affinity purification against the specific antigen

  • Pre-absorb antibody with lysates from SPAC6B12.04c deletion strains

Immunoprecipitation Failure:

• Problem: Poor target protein recovery

• Solutions:

  • Optimize lysis conditions to maintain native protein conformation

  • Try different antibody amounts (2-10 μg per sample)

  • Extend incubation times

  • Use different bead types (Protein A, Protein G, or mixed)

  • Consider covalent coupling of antibody to beads

How can researchers determine the optimal antibody concentration for different experimental applications?

Systematic titration approaches should be used:

Western Blot Titration:

• Prepare a dilution series of antibody (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000)

• Load consistent amounts of positive control protein (e.g., S. pombe lysate)

• Process all blots identically (same blocking, washing, and detection conditions)

• Analyze signal-to-noise ratio at each concentration

• Select the concentration that provides the best balance between specific signal and background

ELISA Optimization:

• Prepare antigen dilution series (coating concentration)

• For each antigen concentration, test antibody dilution series

• Generate a matrix of results

• Select conditions that provide good signal with minimal non-specific binding

• Verify with positive and negative controls

Immunofluorescence Titration:

• Fix and permeabilize cells using standard protocols

• Test antibody at multiple concentrations (1:50, 1:100, 1:200, 1:500)

• Include appropriate controls (secondary antibody only, pre-immune serum)

• Assess signal intensity, specificity, and background

• Document optimal conditions for future reference

Documentation Table Example:

What advanced techniques can be used to study protein-protein interactions involving SPAC6B12.04c?

Multiple advanced approaches can reveal protein interaction networks:

Proximity-Dependent Biotin Identification (BioID):

• Create a fusion of SPAC6B12.04c with a biotin ligase (BirA*)

• Express in S. pombe cells and provide biotin in the medium

• Proteins in proximity to SPAC6B12.04c become biotinylated

• Purify biotinylated proteins using streptavidin beads

• Identify interacting proteins by mass spectrometry

Förster Resonance Energy Transfer (FRET):

• Generate fluorescent protein fusions (e.g., SPAC6B12.04c-CFP and candidate interactor-YFP)

• Express in S. pombe cells

• Measure FRET efficiency using confocal microscopy

• Confirm interactions with positive and negative controls

• Map interaction domains through truncation mutants

Yeast Two-Hybrid Screening:

• Clone SPAC6B12.04c as bait in appropriate vector

• Screen against S. pombe cDNA library

• Identify positive interactions through reporter gene activation

• Validate using co-immunoprecipitation and co-localization studies

• Map interaction domains through deletion constructs

Split-Protein Complementation Assays:

• Fuse SPAC6B12.04c to one fragment of a reporter protein (e.g., split-GFP, split-luciferase)

• Fuse candidate interactors to the complementary fragment

• Co-express in S. pombe cells

• Measure reconstitution of reporter activity

• Validate with other interaction methods

Co-localization Analysis:

• Create fluorescently tagged versions of SPAC6B12.04c and potential interactors

• Express in S. pombe cells

• Analyze using confocal microscopy

• Quantify co-localization using appropriate statistical methods

• Confirm interactions using biochemical approaches

How is SPAC6B12.04c antibody being used in current research on cell wall biogenesis in fungi?

Current research applications include:

Comparative Cell Wall Studies:

• Investigating SPAC6B12.04c localization during different growth phases

• Examining protein levels in response to cell wall stress

• Comparing with other aminotransferases that may contribute to cell wall synthesis

• Studying co-localization with known cell wall synthesis machinery

Septum Formation Research:

• Analyzing SPAC6B12.04c distribution during septation

• Investigating potential interactions with septum-specific proteins

• Examining temporal regulation during the cell cycle

• Comparing localization patterns with Bgs1p and other glucan synthases

Stress Response Pathways:

• Monitoring SPAC6B12.04c levels during different stress conditions

• Investigating post-translational modifications in response to stress

• Examining potential roles in stress granule formation

• Analyzing relationships with stress-responsive transcription factors

Future Research Opportunities:

• Comprehensive interactome mapping of SPAC6B12.04c

• Structure-function analysis to understand enzymatic mechanism

• Investigation of potential roles in amino acid metabolism

• Comparative studies across fungal species to understand evolutionary conservation

What are the implications of studying SPAC6B12.04c for understanding conserved cellular processes across species?

Evolutionary and comparative analyses provide broader context:

Conserved Domains and Functions:

• Aminotransferases are highly conserved across species from bacteria to humans

• Comparison of SPAC6B12.04c with homologs in other organisms can reveal conserved catalytic mechanisms

• Functional studies may uncover fundamental metabolic pathways relevant to multiple species

• Understanding SPAC6B12.04c can provide insights into related human enzymes

Model Organism Advantages:

• S. pombe serves as an excellent model for studying eukaryotic cellular processes

• Findings in fission yeast often translate to higher organisms

• Genetic manipulation is more straightforward in yeast systems

• High-throughput studies are more feasible in model organisms

Translational Potential:

• Insights into fungal cell wall synthesis may inform antifungal drug development

• Understanding aminotransferase function could impact metabolic disease research

• Conserved regulatory mechanisms may apply across species

• Protein interaction networks often show significant conservation

Comparative Genomic Analysis:

• Examination of SPAC6B12.04c orthologs across species

• Analysis of selective pressure on different protein domains

• Investigation of species-specific adaptations in aminotransferase function

• Correlation with ecological niches and metabolic requirements

How can researchers integrate SPAC6B12.04c studies with systems biology approaches to understand metabolic networks?

Systems biology integration provides comprehensive insights:

Multi-omics Integration:

• Combine proteomics data from SPAC6B12.04c immunoprecipitation experiments

• Integrate with transcriptomics data from deletion or overexpression studies

• Incorporate metabolomics to identify affected metabolic pathways

• Use phosphoproteomics to identify regulatory mechanisms

• Build integrated networks using computational approaches

Flux Analysis:

• Use 13C-labeled metabolites to trace metabolic flux in wild-type vs. mutant strains

• Identify metabolic bottlenecks affected by SPAC6B12.04c

• Model metabolic rewiring in response to perturbations

• Connect enzymatic function with cellular phenotypes

Network Modeling:

• Build protein-protein interaction networks centered on SPAC6B12.04c

• Incorporate gene expression data to create condition-specific networks

• Use Boolean or differential equation-based models to predict system behavior

• Validate model predictions with targeted experiments

Integration with Existing Datasets:

• Leverage published S. pombe datasets (e.g., stress response, cell cycle)

• Compare with data from related species (S. cerevisiae, other fungi)

• Use data mining to identify patterns across multiple studies

• Apply machine learning approaches to predict functional relationships

Visualization and Analysis Tools:

• Cytoscape for network visualization and analysis

• R/Bioconductor packages for omics data integration

• KEGG and BioCyc for metabolic pathway mapping

• STRING and BioGRID for protein interaction data

What are the latest developments in high-throughput screening approaches using SPAC6B12.04c antibody?

Emerging high-throughput applications include:

Reverse Phase Protein Arrays (RPPA):

• Spot lysates from multiple conditions/strains on nitrocellulose slides

• Probe with SPAC6B12.04c antibody to determine protein levels

• Analyze hundreds of samples simultaneously

• Quantify expression changes across diverse conditions

Automated Immunofluorescence:

• Use high-content imaging systems to analyze SPAC6B12.04c localization

• Screen genetic or chemical libraries for effects on localization

• Quantify changes in subcellular distribution

• Correlate with phenotypic readouts

Microfluidic Approaches:

• Integrate antibody-based detection with microfluidic cell culture

• Monitor real-time changes in protein levels or localization

• Combined with live-cell imaging for dynamic studies

• Analyze single-cell variation in protein expression

CRISPR Screens:

• Combine genome-wide CRISPR screens with SPAC6B12.04c antibody detection

• Identify genes affecting SPAC6B12.04c levels or localization

• Use fluorescence-activated cell sorting (FACS) for high-throughput selection

• Sequence sgRNA abundance to identify genetic interactions

Future Technological Developments:

• Single-cell proteomics applications

• In situ proximity ligation assays for protein interaction mapping

• Multiplexed antibody detection using bar-coded antibodies

• Integration with spatial transcriptomics for comprehensive cellular analysis

What are the key resources for researchers working with SPAC6B12.04c antibody?

Essential resources for SPAC6B12.04c research include:

Antibody Sources:

• Commercial sources: Cusabio (CSB-PA521112XA01SXV)

• Specificity: Developed against Schizosaccharomyces pombe (strain 972/ATCC 24843)

• Formats: Available in various sizes (0.1ml, 2ml, 10mg)

S. pombe Resources:

• PomBase (https://www.pombase.org/) - Comprehensive S. pombe database

• Genome-wide deletion mutant collections

• ORFeome collections for protein expression

• Strain repositories: National BioResource Project (NBRP), Yeast Genetic Resource Center (YGRC)

Experimental Protocols:

• Chromatin immunoprecipitation methods as described in published studies

• Real-time PCR protocols for expression analysis

• Protein extraction and Western blotting techniques

• Immunoprecipitation and co-immunoprecipitation methods

Bioinformatics Tools:

• BLAST and HMMER for sequence analysis and homology identification

• STRING and BioGRID for interaction networks

• KEGG and BioCyc for metabolic pathway mapping

• PantherDB and InterPro for functional annotation

What controls and standards should be established when setting up a new experimental system with SPAC6B12.04c antibody?

Establishing reliable controls is critical:

Positive Controls:

• Wild-type S. pombe lysate with known expression levels

• Recombinant SPAC6B12.04c protein (if available)

• Epitope-tagged SPAC6B12.04c strains as reference standards

Negative Controls:

• SPAC6B12.04c deletion strain lysate

• Isotype control antibody (same species, same isotype)

• Secondary antibody-only controls

• Pre-immune serum controls

Experimental Standards:

• Establish antibody titration curves for each application

• Create standard curves for quantitative applications

• Document batch-to-batch variations in antibody performance

• Implement consistent protocols for sample preparation

Validation Approaches:

• Confirm specificity using Western blotting

• Verify detection of GFP-tagged or epitope-tagged proteins

• Demonstrate signal reduction in depletion experiments

• Cross-validate findings with orthogonal methods

Documentation Practices:

• Maintain detailed records of antibody source, lot number, and dilutions

• Document optimization experiments and results

• Record any modifications to standard protocols

• Share validation data with laboratory members